Electroporation |
• High levels of transgene expression |
• Invasive |
• Long-lasting gene expression |
• Need for specialist equipment and training |
• Safety demonstrated in numerous clinical trials |
• Potential for tissue damage |
• Commercially available delivery devices |
• Two-step delivery process |
Gene Gun |
• High levels of transgene expression |
• Invasive |
• Long-lasting gene expression |
• Limited DNA carrying capacity |
• Safety demonstrated in clinical trials |
• Need for specialist equipment and training |
• Commercially available delivery devices |
• Often need for multiple administrations |
• One-step delivery process |
• Low tissue penetration |
Ultrasound |
• Non-invasive |
• Low levels of transgene expression |
• Can be targeted to specific organs easily |
• Need for specialist equipment and training |
|
• Two-step delivery process |
• Safety not yet widely demonstrated in gene therapy clinical trials |